More than 50 years ago, niacin was among the first drugs used to lower cholesterol in hopes of preventing heart attack and stroke. Now, in an ironic turn of events, a team working with Stanley Hazen, MD, PhD, Chair of Cardiovascular & Metabolic Sciences at Cleveland Clinic’s Lerner Research Institute, discovered thata substance produced during the breakdown of niacin, 4PY, causes vascular inflammation, a contributor to heart disease.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Heart Advisor
Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!